Palumbo Wealth Management LLC

Source: SEC Form 13F · as of Mar 2026

Palumbo Wealth Management LLC holds 44 biotech & pharma companies tracked by BioSniper, totaling $32.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

44

Total value held

$32.9M

CompanySharesValue
JNJJOHNSON & JOHNSON20,295$5.0M
DGXQuest Diagnostics Incorporated24,302$4.8M
NPCENeuropace Inc.210,469$2.8M
LLYELI LILLY & Co1,099$1.0M
DNTHDianthus Therapeutics, Inc. /DE/10,360$869K
SNDXSyndax Pharmaceuticals Inc37,183$869K
IDYAIDEAYA Biosciences, Inc.22,888$763K
DSGNDesign Therapeutics, Inc.71,408$760K
NVAXNOVAVAX INC92,111$750K
NKTRNEKTAR THERAPEUTICS10,173$732K
DFTXDefinium Therapeutics Inc.37,966$718K
IMNMImmunome Inc.32,051$701K
EVMNEvommune, Inc.29,931$688K
EBSEmergent BioSolutions Inc.80,264$666K
TSHATaysha Gene Therapies, Inc.146,709$656K
PTGXProtagonist Therapeutics, Inc6,083$641K
ABTABBOTT LABORATORIES6,198$636K
MRKMerck & Co., Inc.4,860$585K
KODKodiak Sciences Inc.15,304$583K
PHVSPharvaris N.V.20,608$582K
ANIKAnika Therapeutics Inc.39,426$572K
ASMBASSEMBLY BIOSCIENCES, INC.19,643$545K
XFORX4 Pharmaceuticals, Inc131,014$541K
BEAMBeam Therapeutics Inc.22,348$533K
AMGNAMGEN INC1,486$523K
IMMXImmix Biopharma, Inc.55,232$503K
OFIXOrthofix Medical Inc. Common Stock (DE)40,373$463K
MIRMMirum Pharmaceuticals, Inc.4,986$461K
GMOptec International, Inc.5,908$440K
NUVBNuvation Bio Inc.100,963$433K
OCSOculis Holding AG13,711$365K
PRMEPrime Medicine, Inc.102,246$356K
HRTXHERON THERAPEUTICS, INC. /DE/412,496$330K
CRNXCrinetics Pharmaceuticals, Inc.8,173$297K
ABBVAbbVie Inc.1,227$267K
VYGRVoyager Therapeutics, Inc.62,784$242K
NVSNovartis AG1,537$235K
XNCRXencor Inc17,806$215K
CORCencora Inc.661$208K
ORICOric Pharmaceuticals, Inc.15,548$197K
SANASana Biotechnology, Inc.58,459$168K
ORGOOrganogenesis Holdings Inc.57,849$137K
XERSXeris Biopharma Holdings, Inc.17,788$103K
IMRXImmuneering Corp18,670$98K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.